Stelios Papadopoulos, Ph.D.
Board Member
Ovid Therapeutics Inc. (OVID)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stelios Papadopoulos, Ph.D.
Stelios Papadopoulos, Ph.D. is recorded as Board Member at Ovid Therapeutics Inc. (OVID). Ovid Therapeutics Inc. reported in an 8-K filed March 5, 2025 that Stelios Papadopoulos, Ph.D. was appointed Class I director, effective March 1, 2025.
“On March 1, 2025, the Board of Directors (the "Board") of Ovid Therapeutics Inc. (the "Company") increased the size of the Board from five to six directors and appointed Stelios Papadopoulos, Ph.D., as a Class I director of the Company, with his term expiring at the Company's 2027 annual meeting of stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-03-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ovid Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Margaret "Meg" Alexander CEO, COO, Board Member
- Margaret Alexander CEO, COO, Board Member
- Jeremy M. Levin Chairman
- Charles Carter CFO
- Jeffrey Rona CFO, Chief Accounting Officer
- Anna Greka, M.D., Ph.D. Board Member
- Dr. Kevin Fitzgerald, Ph.D. Board Member
- Dr. Robert Michael Poole Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.